Amman: A new drug has been registered in Russia to cure prostate cancer after proving its effectiveness and withstanding clinical tests, according to Russian health authorities.
According to a statement, the Federal Medical-Biological Agency (FMBA) said, “The drug is used to treat patients with resistant prostate cancer with radionuclide bone metastases.
“The drug has proven its effectiveness as an innovative way to treat patients suffering from this disease.”
Source: Jordan News Agency